Base · 63 · Common · 1999
The raw price over time, with any graded series laid over the same axis — the comparison a grading decision turns on.
Premium25 graded series can be laid over this line — see what the slab did while the raw price moved.Unlock
Every graded price published, next to how many copies exist at that grade.
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶PSA 10 | $255 $208–$360 from sold comps | 40.8× | 2,134 | 0 |
| ▶PSA 9 | $49.99 $30.00–$76.99 from sold comps | 8.0× | 4,534 | 2,134 |
| ▶PSA 8.5 | $43.69 | 7.0× | 14 | 6,668 |
| ▶PSA 8 | $45.30 | 7.2× | 2,750 | 6,682 |
| ▶PSA 7 | $22.25 $12.50–$39.99 from sold comps | 3.6× | 1,290 | 9,433 |
| ▶PSA 6 | $30.00 $25.00–$43.02 from sold comps | 4.8× | 908 | 10,726 |
| ▶PSA 5 | $29.21 | 4.7× | 633 | 11,634 |
| ▶PSA 4 | $18.53 | 3.0× | 236 | 12,267 |
| ▶PSA 3 | $27.41 | 4.4× | 124 | 12,503 |
| ▶PSA 2 | $25.00 | 4.0× | 41 | 12,627 |
| ▶PSA 1 | $58.79 unverified | 9.4× | 54 | 12,668 |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶BGS 9.5 | $48.64 unverified | 7.8× | — | — |
| ▶BGS 9 | $548 | 87.7× | — | — |
| ▶BGS 8.5 | $48.71 unverified | 7.8× | — | — |
| ▶BGS 8 | $288 | 46.1× | — | — |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶CGC 10 | $125 | 20.0× | — | — |
| ▶CGC 9.5 | $48.20 | 7.7× | — | — |
| ▶CGC 9 | $28.00 $17.50–$49.99 | 4.5× | — | — |
| ▶CGC 8.5 | $31.73 | 5.1× | — | — |
| ▶CGC 8 | $25.43 | 4.1× | — | — |
| ▶CGC 7.5 | $12.04 | 1.9× | — | — |
| ▶CGC 7 | $15.68 | 2.5× | — | — |
| ▶CGC 6.5 | $7.79 | 1.2× | — | — |
| ▶CGC 6 | $9.77 | 1.6× | — | — |
| ▶CGC 5.5 | $10.73 | 1.7× | — | — |
| ▶CGC 5 | $15.00 | 2.4× | — | — |
| ▶CGC 4.5 | $15.00 | 2.4× | — | — |
| ▶CGC 3 | $7.00 | 1.1× | — | — |
A model's opinion, not investment advice.